Our Patient-Centered Mission Has Led Us Here
Chronic low back pain steals so much from life—and a type of this pain is called vertebrogenic pain. Thirty years of science and a strong foundation of clinical evidence has driven a clear understanding of vertebrogenic pain—and now our mission is to treat the millions of patients with this condition with the proven and durable Intracept Procedure.
Curious? Let’s live the proof of the Intracept Procedure together.
The Latest Living Proof
Boston Scientific Announces Positive Noridian Local Coverage Determination for the Intracept™ Procedure
Policy expands physician and patient access for vertebrogenic low back pain treatment.
Relievant Medsystems Announces Positive Coverage Policy from Humana for the Intracept Procedure
The coverage went into effect on Thursday, November 2, 2023, and expands access to the procedure, when clinically appropriate, to more than 13 million patients.
Relievant Medsystems Announces Positive Coverage Policy for the Intracept Procedure from Anthem Blue Cross and Blue Shield
The coverage went into effect on Wednesday, September 27, 2023, and expands access to the procedure, when clinically appropriate, to more than 36 million patients.
Looking for Proof?
Hear from the Ones Living It.
Real Intracept Procedure patients tell their stories of lasting relief from vertebrogenic pain.